Literature DB >> 29880235

A systematic view on E3 ligase Ring TRIMmers with a focus on cardiac function and disease.

Ankush Borlepawar1, Norbert Frey1, Ashraf Yusuf Rangrez2.   

Abstract

Ubiquitination, a post-translational modification via ubiquitin-proteasome-system, is one of the vital cellular processes involved in intracellular signaling, cell death, transcriptional control, etc. Importantly, it prevents the aggregation of non-functional, misfolded or unfolded, potentially toxic proteins to maintain cellular protein homeostasis. Ubiquitination is accomplished by the concerted action of three enzymatic steps involving E1 activating enzymes, E2 conjugating enzymes, and E3 ligases. Tripartite motif-containing (TRIM) proteins are one of the integral members of E3 ubiquitin ligases in metazoans modulating essential cellular pathways. For long, MuRFs (Muscle ring finger proteins) were the most extensively studied TRIMs for their cardiac function. Recent research advances in the field and our analysis presented here, however, demonstrated broader and ever increasing involvement of additional TRIM E3 ligases in the pathophysiology of heart. In this review, we summarize the known cardiac E3 ligases and their targets, and discuss their role and importance in cardiac proteostasis, pathophysiology and potential therapeutic implications with specific focus on TRIM E3 ligases.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  E3 ligase; TRIM; Ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 29880235     DOI: 10.1016/j.tcm.2018.05.007

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  9 in total

Review 1.  SRF: a seriously responsible factor in cardiac development and disease.

Authors:  Anushka Deshpande; Prithviraj Manohar Vijaya Shetty; Norbert Frey; Ashraf Yusuf Rangrez
Journal:  J Biomed Sci       Date:  2022-06-09       Impact factor: 12.771

Review 2.  E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis.

Authors:  Santina Venuto; Giuseppe Merla
Journal:  Cells       Date:  2019-05-27       Impact factor: 6.600

3.  Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway.

Authors:  Hui Yang; Xiao-Xiao Wang; Chun-Yu Zhou; Xue Xiao; Cui Tian; Hui-Hua Li; Chun-Lin Yin; Hong-Xia Wang
Journal:  J Cell Mol Med       Date:  2020-04-28       Impact factor: 5.310

4.  Zenglv Fumai Granule protects cardiomyocytes against hypoxia/reoxygenation-induced apoptosis via inhibiting TRIM28 expression.

Authors:  Xiao-Hua Zhang; Hong-Yu Zhao; Yu Wang; Lin Di; Xin-Yu Liu; Feng Qian; Shu-Rong Liu
Journal:  Mol Med Rep       Date:  2021-01-05       Impact factor: 2.952

5.  Salvianolic acid B inhibits myocardial I/R-induced ROS generation and cell apoptosis by regulating the TRIM8/GPX1 pathway.

Authors:  Bo Lu; Jianhua Li; MingTai Gui; Lei Yao; Mingsong Fan; Xunjie Zhou; Deyu Fu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

6.  Comprehensive Analysis of the Expression and Prognosis for Tripartite Motif-Containing Genes in Breast Cancer.

Authors:  Lvwen Ning; Qin Huo; Ni Xie
Journal:  Front Genet       Date:  2022-07-19       Impact factor: 4.772

7.  Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway.

Authors:  Xiao-Yu Jiang; Fei-Fei Guan; Jia-Xin Ma; Wei Dong; Xiao-Long Qi; Xu Zhang; Wei Chen; Shan Gao; Xiang Gao; Shuo Pan; Ji-Zheng Wang; Yuan-Wu Ma; Lian-Feng Zhang; Dan Lu
Journal:  Dis Model Mech       Date:  2022-08-18       Impact factor: 5.732

8.  miR-378a-3p inhibits ischemia/reperfusion-induced apoptosis in H9C2 cardiomyocytes by targeting TRIM55 via the DUSP1-JNK1/2 signaling pathway.

Authors:  Jiaying Tan; Jun Shen; Huigeng Zhu; Ye Gong; Hechen Zhu; Junping Li; Shan Lin; Gang Wu; Tao Sun
Journal:  Aging (Albany NY)       Date:  2020-05-28       Impact factor: 5.682

Review 9.  MuRF1/TRIM63, Master Regulator of Muscle Mass.

Authors:  Dulce Peris-Moreno; Daniel Taillandier; Cécile Polge
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.